Glenmark to conduct phase III trials of nasal spray it claims to be effective in treating COVID-19

By Shalini Bhardwaj New Delhi [India], July 8 (ANI): Glenmark Pharmaceuticals will be conducting a Phase III trial on a nasal spray, which it claims to be effective in the…

Sanofi, GSK receive approval for Phase 3 trial of COVID vaccine in India

New Delhi [India], July 8 (ANI): French pharmaceutical company Sanofi and its British partner GSK (GlaxoSmithKline plc) received approval for their Phase 3 clinical study in India, to assess the…

After release of Covaxin’s phase 3 efficacy data, NTAGI chief says it will help vaccine get WHO recognition

By Shalini Bhardwaj New Delhi [India], (ANI): Hours after Bharat Biotech announced that its vaccine Covaxin's efficacy against COVID-19 is 77.8 per cent, National Technical Advisory Group on Immunisation (NTAGI)…

Bharat Biotech releases Phase 3 trial results of Covaxin, claims vaccine efficacy of 78.8 pc against COVID-19

Hyderabad (Telangana) [India], July 3 (ANI): Hyderabad-based Bharat Biotech on Saturday concluded a final analysis for its vaccine Covaxin efficacy from phase-3 clinical trial claiming it to be 77.8 per…

Bharat Biotech has submitted Covaxin’s Phase III trial data to DCGI: Govt sources

By Shalini Bhardwaj New Delhi [India], June 21 (ANI): The Hyderabad-based COVID vaccine manufacturing company Bharat Biotech submitted data from the Phase III clinical trials of Covaxin to Drugs Controller…